Rxo (RXO) Other Accumulated Expenses (2021 - 2026)

Rxo (RXO) has 6 years of Other Accumulated Expenses data on file, last reported at $10.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 9.09% year-over-year to $10.0 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (down 9.09% YoY), and the FY2025 full-year result was $10.0 million, down 61.54% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $10.0 million, roughly flat from $10.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $26.0 million in Q4 2024 and bottomed at $5.0 million in Q3 2022.
• The 5-year median for Other Accumulated Expenses is $12.0 million (2024), against an average of $12.1 million.
• The widest annual swing landed in 2024, when Other Accumulated Expenses soared 283.33%; it then tumbled 61.54% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $14.0 million in 2022, then decreased by 7.14% to $13.0 million in 2023, then soared by 100.0% to $26.0 million in 2024, then sank by 61.54% to $10.0 million in 2025, then changed by 0.0% to $10.0 million in 2026.
• The last three Other Accumulated Expenses figures came in at $10.0 million (Q1 2026), $10.0 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.

Peer Comparison